IMDI CoRE NeuroControl

Menu

Updates

Profits in the Newspaper!

Adjunct Professorships at NWU Chicago for Neurocontrol Researchers

The Provost of Northwestern University in Chicago, Daniel Linzer, has announced in the presence of King Willem-Alexander and Queen Maxima, that dr. Alfred Schouten (TU Delft), Prof. dr. Gert Kwakkel, dr. Carel Meskers (both VUmc), Dr. Edwin van Asseldonk, Prof. dr. Peter Veltink (both University Twente), Prof. dr. Hans Rietman and dr. Jaap Buurke (both Utwente and Roessingh Research and Development)) are appointed as adjunct professor at Northwestern University of Chicago. In their new role, they will be able to work closely with world-famous researchers on stroke rehabilitation. This will enable them to apply technical inventions in clinical settings more rapidly and bring them to the market more quickly. As Agaath Sluijter business director Neurocontrol puts it, ‘The appointment of the seven new adjunct professors is good news for neurorehabilitation research.’

Neurocontrol and RIC join forces in neurorehabilitation research

In the presence of King Willem-Alexander and Queen Maxima, a Memorandum of Understanding was signed in the United States today between IMDI NeuroControl and the Rehabilitation Institute of Chicago (RIC), confirming the two parties’ collaboration in neurorehabilitation research.

By joining forces, the RIC and the NeuroControl consortium will embark on an extensive research programme to advance the clinical application of neurorehabilitation techniques using Dutch technology. Prof. Frans van der Helm (TU Delft and technical leader at IMDI NeuroControl), Richard Lieber (Chief Scientist and Senior Vice President of Research, RIC), Zev Rymer (Doctor of Medicine, RIC) and Barry Hes (representing MotekForce Link/TMSi) signed the Memorandum of Understanding on Wednesday 3 June in Chicago.

According to Agaath Sluijter, business director at IMDI NeuroControl, ‘The intensified collaboration with RIC will provide more opportunities to train a new generation of clinicians, scientists and engineers within the multidisciplinary framework that will be required for future breakthroughs in the diagnosis and treatment of complex disorders, such as chronic neurological disorders